Company
Legend Biotech Corp (LEGN)
Standardized SEC financial data for Legend Biotech Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001801198 · NASDAQ · Pharmaceutical Preparations.
Gross margin
65.5%
Net margin
-47.3%
Revenue growth (YoY)
120.0%
Return on equity
-29.6%
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $75.0M | $68.8M | $117.0M | $285.1M | $627.2M | — |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total assets | $722.1M | $1.12B | $1.33B | $1.85B | $1.67B | $1.73B |
| Total liabilities |
Get LEGN data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LEGN/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LEGN/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"